The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

The Pathoimmunobiology and Translational Implications of Targeting the PD-1 Checkpoint in Metastatic Cutaneous Squamous Cell Carcinoma (CSCC)

 What Biomarkers, Tumor- and Immune- Centric Mechanisms Underpin Clinical Response in CSCC?


Published

Created by

CMEducation Resources symposium

Related Presenters

Anna Pavlick, DO

Anna Pavlick, DO

Medical Oncologist
Laura and Isaac Perlmutter Cancer Center
New York University Langone Medical Center
New York, NY